CHICAGO – First phase 3 results from an OA trial testing a nerve growth factor antibody, tanezumab.
SAN FRANCISCO – Nearly one-quarter were receiving substantial high-dose opioid prescriptions.
The agency’s approval of Dsuvia comes at a time when the need is great for nonaddictive agents for pain control.
Whether you view marijuana as a recreational compound, a therapeutic tool, or a societal scourge, it is gaining in popularity and acceptance. Like...
Long-term use of opioids, including methadone therapy, increases the risk of central sleep apnea, though adaptive servo ventilation can...
The opioid is to used for only adult patients in settings that are closely controlled.
Topics include: Short-term NSAID use • chronic liver disease & pneumonia • Antibiotic prescribing • fractures in older men • ART for younger...
Which devices do—and don’t—have evidence to support their use when it comes to injuries like carpal tunnel syndrome, “tennis elbow,” or an ankle...
This review can help you refine your approach to the diagnosis and management of adult foot fractures, while offering guidance on when to pursue...
The efficacy of chondroitin and glucosamine for knee osteoarthritis has been questioned for years. Now, the first pharmaceutically sponsored trial...